StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.96+4.67 (+9.88%)

Close on Nov 18, 2026Market cap $1.55BP/E –Yield –

GeneDx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

GeneDx's price to book ratio was 6.7× on Nov 10, 2026, against 16.5× a year earlier. Over the last 5 years it ranged from 0.2× to 16.5×, with a median of 4.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20266.7×−6.2
2025Dec 31, 202512.9×+2.5
2024Dec 31, 202410.3×+10.0
2023Dec 29, 20230.3×+0.1
2022Dec 30, 20220.2×–

More GeneDx figures

See a number that looks wrong?